Secukinumab may be a valid treatment option in patients with CNS demyelination and concurrent ankylosing spondylitis: Report of two clinical cases-Reference-Cited by-同舟云学术

Secukinumab may be a valid treatment option in patients with CNS demyelination and concurrent ankylosing spondylitis: Report of two clinical cases

Published:2019-10 Issue: Volume:35 Page:193-195
ISSN:2211-0348
Container-title:Multiple Sclerosis and Related Disorders
language:en
Short-container-title:Multiple Sclerosis and Related Disorders

Author:

Cortese Antonio^ORCID,Lucchetti Ramona,Altobelli Alessio,Conte Antonella^ORCID,Primavera Marco,Valesini Guido,Millefiorini Enrico,Scrivo Rossana^ORCID

Publisher

Elsevier BV

Subject

Clinical Neurology,Neurology,General Medicine

Reference14 articles.

1. Treatment of psoriasis and psoriatic arthritis with secukinumab after unsatisfactory response to ustekinumab in multiple sclerosis patient;Assefa;J Dermatol.,2018

2. Clustering of autoimmune diseases in families with a high-risk for multiple sclerosis: a descriptive study;Barcellos;Lancet Neurol.,2006

3. "Better explanations" in multiple sclerosis diagnostic workup: a 3-year longitudinal study;Calabrese;Neurology,2019

4. Activity of secukinumab, an anti-IL-17A antibody, on brain lesions in RRMS: results from a randomized, proof-of-concept study;Havrdová;J. Neurol.,2016

5. The occurrence of autoimmune diseases in patients with multiple sclerosis and their families;Henderson;J. Clin. Neurosci.,2000

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cerebral Tumefactive Inflammatory Lesion Occurrence During Ixekizumab Treatment in a Patient With Active Psoriatic Arthritis;The Neurologist;2024-01-22

2. Therapeutic consequences in patients with both inflammatory rheumatic diseases and multiple sclerosis;Rheumatology;2022-11-28

3. Th17 cells and inflammation in neurological disorders: Possible mechanisms of action;Frontiers in Immunology;2022-07-22

4. Secukinumab in the treatment of psoriatic arthritis or ankylosing spondyloarthritis with multiple sclerosis: a case series with literature review;Immunotherapy;2022-04

5. Italian adaptation of EuroGuiDerm guideline on the systemic treatment of chronic plaque psoriasis;Italian Journal of Dermatology and Venereology;2022-03